Press release
Global Peripheral Neuropathy Market Growth Driven by Key Sectors: Highlights from Market Research Reports
Peripheral Neuropathy Market
Chemotherapy-induced peripheral neuropathy (CIPN) is another growing concern, affecting 30-40% of cancer patients undergoing neurotoxic chemotherapy. New drug developments like APX-3330 from Apexian Pharmaceuticals show promise in reducing the severity of nerve damage and discomfort in patients. This push for better treatments highlights the significant unmet medical needs and offers optimism for future growth in the peripheral neuropathy market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2757
Materials and Chemicals: Innovations in Product Segmentation Several reports have also focused on the rapid evolution of the materials and chemicals sectors. Products like glacial acetic acid, fiber-reinforced polymer panels, and high-density polyethylene (HDPE) are showing strong market growth driven by demand from various industries such as construction, packaging, and industrial manufacturing.
For instance, the market for HDPE has benefited from the increased need for lightweight yet durable materials. Its use in industries such as automotive and packaging underscores the rising demand for efficient and sustainable alternatives. Similarly, fiber-reinforced polymer panels are increasingly utilized in construction due to their strength and flexibility, further bolstering their market presence.
Sustainability and Green Initiatives: A Growing Trend Sustainability is a central focus across many sectors, as reflected in reports on markets such as green bio-based solvents and water-based enamel. Green solvents are seeing a surge in demand due to their eco-friendly properties, particularly in North America, Europe, and Asia-Pacific. With consumers and businesses prioritizing sustainability, green bio-based solvents offer a viable alternative to traditional, harmful chemicals.
Similarly, water-based enamel coatings are gaining traction in the global market as industries shift towards reducing volatile organic compound (VOC) emissions. These products provide durable and protective finishes while minimizing environmental impact, driving demand from industries like automotive and construction.
Innovations in the Aerospace and Defense Materials Market In the aerospace and defense sectors, advancements in materials such as lightweight composites and alloys are crucial for improving efficiency and safety. The market for aerospace defense materials is expanding as manufacturers seek materials that offer high strength-to-weight ratios, corrosion resistance, and the ability to withstand extreme environments. This market's growth is largely driven by the increasing need for fuel-efficient aircraft and innovative defense technologies.
Chemicals Sector: Expanding Opportunities in Niche Markets The chemicals market has shown robust growth across various segments, with specific reports highlighting products such as perfluorocarbons, ethylene amine, and strontium. These chemicals are essential in industries ranging from healthcare to electronics. For instance, perfluorocarbons are increasingly used in the medical field for oxygen transportation, while strontium is vital in producing specialty alloys and electronic components.
The demand for ethylene amine is rising, driven by its application in agriculture, pharmaceuticals, and textiles. This market is expected to grow further due to its versatility and increasing use in multiple industries.
Request For An Discount@ https://www.emergenresearch.com/request-discount/2757
Peripheral Neuropathy Top Companies and Competitive Landscape
The global peripheral neuropathy market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peripheral neuropathy solutions.
Some major players included in the global peripheral neuropathy market report are:
Assertio Holdings, Inc
AstraZeneca
Abbott
Cadila Pharmaceuticals
Cipla Inc
DAIICHI SANKYO COMPANY, LIMITED
Reddy's Laboratories Ltd
Eli Lilly and Co.
Endo International plc
Grünenthal
Hikma Pharmaceuticals PLC
Johnson & Johnson, Inc
Lupin
Novartis AG
Pfizer Inc
Shionogi & Co., Ltd
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
UCB S.A.
Viatris Inc
Peripheral Neuropathy Latest Industry Updates
On 16 August 2022, Yostra Labs announced that the Indian Angel Network (IAN)-led seed investment round had yielded USD 0.56 million. Other participants included Impact Innovators and Entrepreneurs Foundation (Villgro Innovations Foundation) and the Centre for Cellular and Molecular Platforms. Yostra offers a line of unique diabetes neuropathy-focused devices that can prevent complications and improve the quality of life for those with the disease. The investment from IAN and co-investors is intended to enhance the company's market share, facilitate the commercialization of its product line, optimize the bill of materials, and increase production.
On 27 July 2023, Asprius Lifesciences announced the development of a drug for the treatment of Diabetic Neuropathy, a disorder causing damage to nerves in the body's peripheral regions. The company has already submitted a patent application for the Fixed-Dose Combination (FDC), which holds potential as a treatment for peripheral neuropathy, a common ailment affecting over 2% of the world's population. Asprius Lifesciences aims to mitigate the effects of neuropathy by providing neuro-protective drugs and addressing medical disorders that increase the risk of neuropathy development.
For more informative information, please visit us @ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market
For the purpose of this report, Emergen Research has segmented global peripheral neuropathy market on the basis of type, treatment method, route of administration, diagnosis, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
Diabetic Peripheral Neuropathy
Chemotherapy-Induced Peripheral Neuropathy
Idiopathic Peripheral Neuropathy
HIV/AIDS Associated Peripheral Neuropathy
Treatment Method Outlook (Revenue, USD Billion; 2019-2032)
Pharmacological Therapies
Pain Relievers
Anti-Seizure Medications
Anti-Depressants
Non-Pharmacological Therapies
Transcutaneous Electrical Nerve Stimulation
Plasma Exchange
Others
Others
Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
Oral
Parenteral
Others
Diagnosis Outlook (Revenue, USD Billion; 2019-2032)
Blood Test
Biopsy
Imaging
Others
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals and Clinics
Retail Pharmacy
Online Pharmacy
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Look Over transcripts provided by Emergen Research
Peripheral Neuropathy Market Size@ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market/market-size
Peripheral Neuropathy Market Share@ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market/market-share
Peripheral Neuropathy Market Trends@ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market/market-trends
Peripheral Neuropathy Regional Market Demand@ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market/regional-market-demand
Peripheral Neuropathy Market Analysis@ https://www.emergenresearch.com/industry-report/peripheral-neuropathy-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peripheral Neuropathy Market Growth Driven by Key Sectors: Highlights from Market Research Reports here
News-ID: 3685083 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Neuropathy
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Combatting Peripheral Neuropathy: Breakthroughs and Beyond
The Business Research Company recently released a comprehensive report on the Global Peripheral Neuropathy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the peripheral neuropathy market…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
